Cost-effectiveness analysis of mirvetuximab soravtansine in treating recurrent， platinum-resistant， folate receptor α-positive ovarian cancer
WU Yilai, HE Yinmei, LUAN Jiajie, ZHANG Wen
Chinese Journal of Hospital Pharmacy . 2025, (21): 2479 -2484 .  DOI: 10.13286/j.1001-5213.2025.21.09

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat